November 30, 2015
Cipla launching low-dose Efavirenz 400 mg HIV infection therapy
Cipla launching low-dose Efavirenz 400 mg HIV infection therapy
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
November 30, 2015
Teva and Takeda are forming a new joint venture to operate generics in Japan
Teva and Takeda are forming a new joint venture to operate in Japan
November 30, 2015
Faron: Clevegen can be used as immunotherapy product
A publication on Clever-1 function related to Faron Pharmaceuticals’ novel cancer immunotherapy antibody Clevegen, was published in journal of the American Association of Immunology.
November 30, 2015
India progresses towards polio-free world
“Ours will be the last generation to see the horror of children paralyzed or killed by polio. I am sure,” said Pr Jacob John, Former Christian Medical College, Vellore, Tamil Nadu, India.
“Maybe we will remember 2015 as the year we took the final step to eradicate this disease forever.”
November 27, 2015
Exclusive: Lazard works with Sanofi on $12.7 billion animal health unit deal – sources
By Pamela Barbaglia, Olivia Oran and Arno Schuetze LONDON/NEW YORK/FRANKFURT (Reuters) – Investment bank Lazard is working with Sanofi’s management…
November 27, 2015
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
Two-decade Pfizer mission pays off for Gueggenheim’s deal king
November 27, 2015
EU opens door for Impax’s Parkinson’s treating oral capsule Numient
Impax Laboratories has been granted by the European Commission (EC) authorization to market its Numient oral capsule formulation for the symptomatic treatment of adult patients with Parkinson’s disease.
November 27, 2015
No revenues for Kiadis Pharma in the first 9 months 2015
Kiadis Pharma did not generate any revenues in the first nine months of 2015, the company said Friday.
November 27, 2015
(Edited) RPG Life Science calms down investors. Says media writings are premature
RPG Life Science Limited has said that the media reports which said that “RPG Life Plans Skincare Foray, May Roll Out Biz Next Month” came out premature.